Intensive Tx Yields Long-Term Gain in Type 1 Diabetes

ADA 2013 — CHICAGO — Benefits seen with intensive therapy for type 1 diabetes in a large epidemiological study persist through extended follow-up, according to the latest data from the DCCT/EDIC trial.


< Back to Listings